Selepressin, a novel selective vasopressin V(1A) agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients

Benzer Materyaller

• A Selective V(1A) Receptor Agonist, Selepressin, Is Superior to Arginine Vasopressin and to Norepinephrine in Ovine Septic Shock*
  Yazar:: He, Xinrong, ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• Arginine vasopressin in septic shock: supplement or substitute for norepinephrine?
  Yazar:: Rehberg, Sebastian, ve diğerleri
  Baskı/Yayın Bilgisi: (2009)
• Effect of Selepressin vs Placebo on Ventilator- and Vasopressor-Free Days in Patients With Septic Shock: The SEPSIS-ACT Randomized Clinical Trial
  Yazar:: Laterre, Pierre-Francois, ve diğerleri
  Baskı/Yayın Bilgisi: (2019)
• Comparison Between Norepinephrine Alone Versus Norepinephrine/Vasopressin Combination for Resuscitation in Septic Shock
  Yazar:: Rania M. Hussien, ve diğerleri
  Baskı/Yayın Bilgisi: (2021-05-01)
• Cardiac ischemia in patients with septic shock randomized to vasopressin or norepinephrine
  Yazar:: Mehta, Sangeeta, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)